Skip to content

An Efficacy and Safety Study of Fentanyl Transdermal Patch in Filipino Participants With Osteoarthritis and Chronic Low Back Pain

CompletedPhase 4NCT01795898
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this study is to evaluate the efficacy and safety of fentanyl among Filipino participants with osteoarthritis (disorder which is seen mostly in older persons in which the joints become painful and stiff) and chronic (lasting a long time) low back pain.

Study details

Official title
Efficacy, Safety and Quality of Life Outcome of Fentanyl Transdermal Patch (Durogesic-D-Trans) Among Filipino Patients With Osteoarthritis and Chronic Low Back Pain
Interventions
Sponsor
Janssen Pharmaceutica
Start date
2009-01
Primary completion
2009-09
Sex
All
Age range
from 18 Years to 65 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
Philippines
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Participants diagnosed with osteoarthritis and chronic low back pain * 3 months of persistent moderate to severe pain levels * More than 3 times a week frequency or daily moderate to severe pain * Moderate to severe pain at Baseline (at least a score of 4 in the 11-point numerical pain scale) Exclusion Criteria * History of allergy to fentanyl transdermal patch or its components and history of illicit drug use for the past 3 months * Active skin disease preventing application of the transdermal system * Chronic pulmonary disease (lung disorder) * Participants susceptible to intracranial (inside the skull) effects of carbon dioxide retention * Pregnant and breastfeeding mothers

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01795898